Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery
Stopped Per PI
Conditions
- Malignant Chest Wall Neoplasm
- Recurrent Breast Carcinoma
- Recurrent Inflammatory Breast Carcinoma
- Stage IV Breast Cancer AJCC v6 and v7
- Stage IV Inflammatory Breast Carcinoma
Interventions
- OTHER: Laboratory Biomarker Analysis
- BIOLOGICAL: Talimogene Laherparepvec
Sponsor
M.D. Anderson Cancer Center
Collaborators